Pharmacogenomics of Pain Management: The Impact of Specific Biological Polymorphisms on Drugs and Metabolism

MLA

Alan D. Kaye, et al. “Pharmacogenomics of Pain Management: The Impact of Specific Biological Polymorphisms on Drugs and Metabolism.” Current Oncology Reports, vol. 22, Feb. 2020. EBSCOhost, https://doi.org/10.1007/s11912-020-0865-4.

APA

Alan D. Kaye, Narjeet Khurmi, Elyse M. Cornett, G Jason Huang, Michelle A. Carroll Turpin, Allison M. Pinner, Tamizh Selvan Gnana Sekaran, Harish Siddaiah, Richard D. Urman, Pankaj Thakur, Jasmine Rivas, Cain W. Stark, Anitha Senthil, Anna Yates, & Jenna L Miller. (2020). Pharmacogenomics of Pain Management: The Impact of Specific Biological Polymorphisms on Drugs and Metabolism. Current Oncology Reports, 22. https://doi.org/10.1007/s11912-020-0865-4

Chicago

Alan D. Kaye, Narjeet Khurmi, Elyse M. Cornett, G Jason Huang, Michelle A. Carroll Turpin, Allison M. Pinner, Tamizh Selvan Gnana Sekaran, et al. 2020. “Pharmacogenomics of Pain Management: The Impact of Specific Biological Polymorphisms on Drugs and Metabolism.” Current Oncology Reports 22 (February). doi:10.1007/s11912-020-0865-4.